T. Rowe Price Associates
OPK icon

T. Rowe Price Associates’s Opko Health OPK Stock Holding History

T. Rowe Price Associates’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$462K Buy
404,652
+37,461
+10% +$46.1K ﹤0.01% 2501
2025
Q4 		$463K Buy
367,191
+23,905
+7% +$33.3K ﹤0.01% 2431
2025
Q3 		$533K Sell
343,286
-94,220
-22% -$129K ﹤0.01% 2331
2025
Q2 		$578K Sell
437,506
-64,162
-13% -$87.7K ﹤0.01% 2238
2025
Q1 		$833K Buy
501,668
+46,147
+10% +$76K ﹤0.01% 2048
2024
Q4 		$670K Buy
455,521
+18,571
+4% +$28.4K ﹤0.01% 2157
2024
Q3 		$652K Buy
436,950
+3,902
+0.9% +$5.79K ﹤0.01% 2145
2024
Q2 		$542K Sell
433,048
-12,933
-3% -$16.8K ﹤0.01% 2165
2024
Q1 		$536K Buy
445,981
+17,671
+4% +$17.7K ﹤0.01% 2183
2023
Q4 		$647K Buy
428,310
+29,117
+7% +$42.1K ﹤0.01% 2063
2023
Q3 		$639K Sell
399,193
-10,999
-3% -$20K ﹤0.01% 1996
2023
Q2 		$891K Buy
410,192
+5,163
+1% +$8.08K ﹤0.01% 1868
2023
Q1 		$592K Buy
405,029
+47,232
+13% +$60.8K ﹤0.01% 2031
2022
Q4 		$447K Buy
357,797
+85,739
+32% +$135K ﹤0.01% 2181
2022
Q3 		$515K Sell
272,058
-3,543
-1% -$8.38K ﹤0.01% 2109
2022
Q2 		$697K Buy
275,601
+3,096
+1% +$9.03K ﹤0.01% 2064
2022
Q1 		$937K Sell
272,505
-12,169
-4% -$43K ﹤0.01% 2041
2021
Q4 		$1.37M Hold
284,674
– – ﹤0.01% 1866
2021
Q3 		$1.04M Hold
284,674
– – ﹤0.01% 2047
2021
Q2 		$1.15M Sell
284,674
-7,523
-3% -$29.5K ﹤0.01% 2012
2021
Q1 		$1.25M Buy
292,197
+47,027
+19% +$225K ﹤0.01% 1939
2020
Q4 		$968K Buy
245,170
+74,030
+43% +$309K ﹤0.01% 1958
2020
Q3 		$632K Buy
171,140
+115,920
+210% +$489K ﹤0.01% 1995
2020
Q2 		$188K Sell
55,220
-188,146
-77% -$421K ﹤0.01% 2363
2020
Q1 		$326K Buy
243,366
+144,677
+147% +$227K ﹤0.01% 2162
2019
Q4 		$145K Sell
98,689
-159,633
-62% -$267K ﹤0.01% 2435
2019
Q3 		$540K Buy
258,322
+1,815
+0.7% +$3.71K ﹤0.01% 2068
2019
Q2 		$626K Buy
256,507
+1,081
+0.4% +$2.36K ﹤0.01% 2021
2019
Q1 		$667K Buy
255,426
+2,380
+0.9% +$7.21K ﹤0.01% 2015
2018
Q4 		$762K Buy
253,046
+141,981
+128% +$481K ﹤0.01% 1916
2018
Q3 		$384K Buy
111,065
+37,718
+51% +$200K ﹤0.01% 2255
2018
Q2 		$345K Buy
73,347
+14,601
+25% +$55.4K ﹤0.01% 2302
2018
Q1 		$186K Buy
58,746
+553
+1% +$2.23K ﹤0.01% 2428
2017
Q4 		$285K Sell
58,193
-9,600
-14% -$55.7K ﹤0.01% 2301
2017
Q3 		$465K Hold
67,793
– – ﹤0.01% 2120
2017
Q2 		$446K Sell
67,793
-908,370
-93% -$6.37M ﹤0.01% 2098
2017
Q1 		$7.81M Buy
976,163
+87,362
+10% +$736K ﹤0.01% 1375
2016
Q4 		$8.27M Sell
888,801
-59,070
-6% -$611K ﹤0.01% 1350
2016
Q3 		$10M Buy
947,871
+28,700
+3% +$286K ﹤0.01% 1318
2016
Q2 		$8.59M Sell
919,171
-4,000
-0.4% -$40.6K ﹤0.01% 1317
2016
Q1 		$9.59M Sell
923,171
-41,350
-4% -$378K ﹤0.01% 1281
2015
Q4 		$9.69M Buy
964,521
+59,021
+7% +$592K ﹤0.01% 1290
2015
Q3 		$7.62M Buy
905,500
+59,800
+7% +$791K ﹤0.01% 1365
2015
Q2 		$13.6M Buy
845,700
+174,000
+26% +$2.71M ﹤0.01% 1261
2015
Q1 		$9.52M Buy
671,700
+107,800
+19% +$1.4M ﹤0.01% 1349
2014
Q4 		$5.63M Buy
563,900
+111,300
+25% +$953K ﹤0.01% 1442
2014
Q3 		$3.85M Buy
452,600
+27,600
+6% +$243K ﹤0.01% 1494
2014
Q2 		$3.76M Buy
425,000
+93,000
+28% +$812K ﹤0.01% 1487
2014
Q1 		$3.09M Buy
332,000
+20,700
+7% +$181K ﹤0.01% 1492
2013
Q4 		$2.63M Buy
311,300
+276,600
+797% +$2.8M ﹤0.01% 1499
2013
Q3 		$306K Buy
34,700
+18,800
+118% +$151K ﹤0.01% 2108
2013
Q2 		$113K Buy
+15,900
New +$110K ﹤0.01% 2320

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates's OPK Position: Q1 2026 in Review

T. Rowe Price Associates increased its Opko Health (OPK) stake by 10% in Q1 2026, buying an estimated $46.1K and bringing the position to 404,652 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #2501.

T. Rowe Price Associates first reported a position in OPK in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.6M in Q2 2015. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • T. Rowe Price Associates held 404,652 shares of Opko Health worth $462K as of Q1 2026.
  • T. Rowe Price Associates bought 37,461 Opko Health shares in Q1 2026, an estimated $46.1K.
  • Opko Health made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2501 holding.
  • T. Rowe Price Associates first reported a position in Opko Health in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Opko Health position peaked at $13.6M in Q2 2015.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.